AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

S A Miles, A R Rezai, J F Salazar-González, M Vander Meyden, R H Stevens, D M Logan, R T Mitsuyasu, T Taga, T Hirano, T Kishimoto, S A Miles, A R Rezai, J F Salazar-González, M Vander Meyden, R H Stevens, D M Logan, R T Mitsuyasu, T Taga, T Hirano, T Kishimoto

Abstract

Cell lines derived from Kaposi sarcoma lesions of patients with AIDS (AIDS-KS cells) produce several cytokines, including an endothelial cell growth factor, interleukin 1 beta, and basic fibroblast growth factor. Since exposure to human immunodeficiency virus increases interleukin 6 (IL-6) production in monocytes and endothelial cells produce IL-6, we examined IL-6 expression and response in AIDS-KS cell lines and IL-6 expression in AIDS Kaposi sarcoma tissue. The AIDS-KS cell lines (N521J and EKS3) secreted large amounts of immunoreactive and biologically active IL-6. We found both IL-6 and IL-6 receptor (IL-6-R) RNA by slot blot hybridization analysis of AIDS-KS cells. The IL-6-R was functional, as [3H]thymidine incorporation by AIDS-KS cells increased significantly after exposure to human recombinant IL-6 (hrIL-6) at greater than 10 units/ml. When AIDS-KS cells (EKS3) were exposed to IL-6 antisense oligonucleotide, cellular proliferation decreased by nearly two-thirds, with a corresponding decrease in the production of IL-6. The decrease from IL-6 antisense in AIDS-KS cell proliferation was reversed by the addition of hrIL-6. We confirmed that AIDS-KS cells produced IL-6 in vivo by preparing RNA and tissue sections from involved and uninvolved skin from a patient with AIDS Kaposi sarcoma. We detected immunoreactive IL-6 in the involved tumor areas and to a lesser extent in the surrounding normal epidermis. Slot blot hybridization showed a great excess of IL-6 and IL-6-R RNA in involved skin compared to uninvolved skin. These results show that both IL-6 and IL-6-R are produced by AIDS-KS cells and that IL-6 is required for optimal AIDS-KS cell proliferation, and they suggest that IL-6 is an autocrine growth factor for AIDS-KS cells.

References

    1. Science. 1988 Oct 21;242(4877):426-30
    1. Science. 1988 Oct 21;242(4877):430-3
    1. Nature. 1988 Mar 3;332(6159):83-5
    1. Am J Clin Pathol. 1985 Jan;83(1):27-33
    1. J Rheumatol. 1986 Jun;13(3):637-40
    1. J Exp Med. 1988 Jun 1;167(6):1951-6
    1. Annu Rev Immunol. 1988;6:485-512
    1. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251-5
    1. Ann N Y Acad Sci. 1989;557:181-90, discussion 190-1
    1. Ann N Y Acad Sci. 1989;557:374-85; discussion 386-7
    1. J Immunol. 1989 Jan 15;142(2):531-6
    1. Ann N Y Acad Sci. 1989;557:466-76; discussion 476-7
    1. Eur J Immunol. 1988 Jun;18(6):951-6
    1. EMBO J. 1987 Oct;6(10):2939-45
    1. Science. 1987 Feb 13;235(4790):731-2
    1. Nature. 1986 Nov 6-12;324(6092):73-6
    1. J Immunol. 1990 Jan 15;144(2):480-4
    1. Clin Exp Dermatol. 1978 Jun;3(2):135-46
    1. Arch Dermatol. 1974 Oct;110(4):602-4
    1. Science. 1988 Aug 12;241(4867):825-8
    1. Science. 1989 Jan 13;243(4888):223-6

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe